| 1. Yingying Ma#，Shuyuan Wang#，Yijie Jia#，Shijie Wang，Wendian Liu，Jiaxin Yu，Jun Wang，Jingkai Geng，Jiayi Zhao，Zheng Zhao*，Juan Xu*，Hui Liu*.Enhancer RNA-mediated transcriptional regulatory programs reveal the malignant progression of glioma.Science Advances.2025.11(23).eadu9487.SCI(含SCIE) |
| 2. Jinhao Zhang，Changlin Yang，Changyuan Ren，Ji Shi，Hanxiao Zhou，Ying Zhang，Zhiyan Sun*，Tao Jiang*，Zheng Zhao*.eccDNABase: A Comprehensive and High-Quality Database for Extrachromosomal Circular DNA. Molecular Biology and Evolution.Molecular Biology and Evolution.2025.42(10).1-9.SCI(含SCIE) |
| 3. Josip Cvitković，Wenlu Tan，Tao Jiang*，Zheng Zhao*.Glioma tumor microenvironment and immunotherapy: past, present, and future.Biomarker Research.2025.13(1).150.SCI(含SCIE) |
| 4. Cell Reports.Multi-omics-guided characterization of neoantigens improves patient stratification and potentiates combinatorial immunotherapy in glioma.Cell Reports.2025.44(12).116704.SCI(含SCIE) |
| 5. Zhiyan Sun#，Changlin Yang#，Lijie Huang#，Zongchao Mo#，Ke’Nan Zhang，Wenhua Fan，Kuanyu Wang，Fan Wu，Jiguang Wang，Fanlin Meng*，Zheng Zhao*，Tao Jiang*.circRNADisease v2.0: an updated resource for high-quality experimentally supported circRNA-disease associations.Nucleic Acids Research.2024.52(D1).D1193-D1200.SCI(含SCIE) |
| 6. Jing Feng#, Zheng Zhao#, Yanfei Wei#, Zhaoshi Bao#, Wei Zhang, Fan Wu, Guanzhang Li, Zhiyan Sun, Yanli Tan, Jiuyi Li, Yunqiu Zhang, Zejun Duan, Xueling Qi, Kai Yu, Zhengmin Cong, Junjie Yang, Yaxin Wang, Yingyu Sun, Fuchou Tang, Xiaodong Su, Chuan Fang*, Tao Jiang* and Xiaolong Fan*.Temporal and spatial stability of the EM/PM molecular subtypes in adult diffuse glioma.Frontiers of Medicine.2023.17(2).240-262.SCI(含SCIE) |
| 7. Si Sun#, Changlin Yang#, Kuanyu Wang#, Ruoyu Huang, Ke-Nan Zhang, Yanwei Liu, Zhi Cao*, Zheng Zhao* and Tao Jiang*.Molecular and clinical characterization of PTRF in glioma via 1,022 samples.BMC Cancer.2023.23(1).551-563.SCI(含SCIE) |
| 8. Yiyun Chen#， Ran Huo#，Weirong Kang#，Yuwei Liu#，Zheng Zhao#，Weilun Fu，Ruochen Ma，Xiaomeng Zhang，Jihong Tang，Zhihan Zhu，Qingyang Lyu，Yi Huang，Mengli Yan，Biaobin Jiang，Ruichao Chai，Zhaoshi Bao，Zheng Hu，Weiping Wang*，Tao Jiang*，Yong Cao* ，Jiguang Wang*.Tumor-associated monocytes promote mesenchymal transformation through EGFR signaling in glioma.Cell Reports Medicine.2023.4(9).101177.SCI(含SCIE) |
| 9. Zhiliang Wang#, Ruoyu Huang#, Bo Han, Fan Wu, Zhiyan Sun, Guanzhang Li, Wei Zhang, Zheng Zhao* and Xing Liu*.Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development.Chinese Neurosurgical Journal.2022.8(1).34-47.自主认定核心期刊 |
| 10. Zheng Zhao#, Ke-Nan Zhang#, Zhiyan Sun#, Changlin Yang#, Qiangwei Wang, Guanzhang Li, Zhiliang Wang, Fan Zeng, Ruichao Chai, Zenghui Qian, Zheng Wang, Yanwei Liu, Wenping Ma*, Fan Wu* and Tao Jiang*.WES data from 286 diffuse gliomas under the 2021 WHO classifcation of tumors of the central nervous system.Scientific Data.2022.9(1).692.SCI(含SCIE) |
| 11. Ke-Nan Zhang#, Zheng Zhao#, Jing Chen#, Zhaoshi Bao#, Ruichao Chai#, Zhiyan Sun, Lingxiang Wu, Zhiliang Wang, Hanjie Liu, Quanhua Mu, Huimin Hu, Fan Zeng, Zheng Wang, Guanzhang Li, Yuanhao Chang, Qiangwei Wang, Fan Wu, Ying Zhang, Yuqing Liu, Chunjie Jiang, Ulf Dietrich Kahlert, Do??Hyun Nam, Wei.MET fusions and splicing variants convergently define a subgroup of glioma sensitive to MET inhibitors.Holistic Integrative Oncology.2022.1.1-18.自主认定核心期刊 |
| 12. Fanlin Meng#, Ke-Nan Zhang#, Changlin Yang#, Ke Zhang, Quan Xu, Ruifang Ren, Yiming Zhou, Yimin Sun, Yan Peng, Yanze Li*, Hongyan Guo*, Yonghong Ren* and Zheng Zhao*.Prognostic pathways guide drug indications in pan-cancers.Frontiers in Oncology.2022.12.849552.SCI(含SCIE) |
| 13. Lingxiang Wu#, Wei Wu#, Junxia Zhang#, Zheng Zhao#, Liangyu Li, Mengyan Zhu, Min Wu, Fan Wu, Fengqi Zhou, Yuxin Du, Ruichao Chai, Wei Zhang, Xiaoguang Qiu, Quanzhong Liu, Ziyu Wang, Jie Li, Kening Li, Apeng Chen, Yinan Jiang, Xiangwei Xiao, Han Zou, Rashmi Srivastava, Tingting Zhang, Yun Cai, Yu.Natural coevolution of tumor and immunoenvironment in glioblastoma.Cancer Discovery.2022.12(12).2820-2837.SCI(含SCIE) |
| 14. Zheng Zhao#, Ke-Nan Zhang#, Qiangwei Wang#, Guanzhang Li, Fan Zeng, Ying Zhang, Fan Wu, Ruichao Chai, Zheng Wang, Chuanbao Zhang, Wei Zhang, Zhaoshi Bao* and Tao Jiang*.Chinese Glioma Genome Atlas (CGGA): A comprehensive resource with functional genomic data from Chinese gliomas.Genomics Proteomics & Bioinformatics.2021.19(1).1-12.SCI(含SCIE) |
| 15. Zheng Zhao#, Zheng Wang#, Zhaoshi Bao, Weizhen Gao, Yuanda Zhang, Cijie Ruan, Tao Lv, Yong Wang and Lihua Sun*.Mutation and alterations analysis of KIF23 in glioma.Frontiers in Genetics.2021.12.646929.SCI(含SCIE) |
| 16. Fan Wu#, Yanwei Liu#, Guanzhang Li#, You Zhai, Yuemei Feng, Wenping Ma, Zheng Zhao* and Wei Zhang*.Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes.British Journal of Cancer.2021.125(2).255-264.SCI(含SCIE) |
| 17. Shupeng Li#, Lulu Li#, Xiangqi Meng, Penggang Sun, Yi Liu, Yuntang Song, Sijia Zhang, Chuanlu Jiang*, Jinquan Cai* and Zheng Zhao*.DREAM: a database of experimentally supported protein-coding RNAs and drug associations in human cancer.Molecular Cancer.2021.20(1).148.SCI(含SCIE) |
| 18. Ying Zhang, Wenping Ma, Wenhua Fan, Changyuan Ren, Jianbao Xu, Fan Zeng, Zhaoshi Bao, Tao Jiang* and Zheng Zhao*.Comprehensive transcriptomic characterization reveals core genes and module associated with immunological changes via 1,619 samples of brain glioma.Cell Death & Disease.2021.12(12).1140.SCI(含SCIE) |
| 19. Zenghui Qian#, Wenhua Fan#, Fanlin Meng#, Zhiyan Sun#, Guanzhang Li, You Zhai, Yuanhao Chang, Changlin Yang, Fan Zeng*, Ruichao Chai*, Fan Wu* and Zheng Zhao*.Molecular characterization and clinical relevance of ANXA1 in gliomas via 1,018 Chinese cohort patients.Frontiers in Cell and Developmental Biology.2021.9.777182.SCI(含SCIE) |
| 20. Lulu Li#, Pengfei Wu#, Zhenyu Wang, Xiangqi Meng, Caijun Zha, Ziwei Li, Tengfei Qi, Yangong Zhang, Bo Han, Shupeng Li, Chuanlu Jiang*, Zheng Zhao* and Jinquan Cai*.NoncoRNA: a database of experimentally supported non-coding RNAs and drug targets in cancer.Journal of Hematology & Oncology.2020.14(9).15.SCI(含SCIE) |
| 21. Fan Zeng#, Kuanyu Wang#, Xiu Liu and Zheng Zhao*.Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma.Cell Communication and Signaling.2020.18(1).2.SCI(含SCIE) |
| 22. Yuchen Shi#, Hui Liu#, Changbo Yang#, Kang Xu#, Yangyang Cai, Zhao Wang, Zheng Zhao*, Tingting Shao* and Yixue Li*.Transcriptomic analyses for identification and prioritization of genes associated with alzheimer’s disease in humans.Frontiers in Bioengineering and Biotechnology.2020.8.31.SCI(含SCIE) |
| 23. Fan Wu#, Zhiliang Wang#, Kuanyu Wang#, Guanzhang Li#, Ruichao Chai, Yuqing Liu, Haoyu Jiang, You Zhai, Yuemei Feng, Zheng Zhao* and Wei Zhang*.Classification of diffuse lower-grade glioma based on immunological profiling.Molecular Oncology.2020.14(9).2081-2095.SCI(含SCIE) |
| 24. Zheng Zhao#, Guanzhang Li#, Yuqing Liu#, Ruoyu Huang#, Kuanyu Wang, Haoyu Jiang, Renpeng Li, Ruichao Chai*, Chuanbao Zhang* and Fan Wu*.Characterization and prognostic significance of alternative splicing events in lower-grade diffuse gliomas.Journal of Cellular and Molecular Medicine.2020.24(22).13171-13180.SCI(含SCIE) |
